ADIPOQ and thyroid cancer: Emerging evidence highlights the dysregulation of adipokine homeostasis—particularly reduced adiponectin and elevated leptin levels in obesity—as critical mediators of thyroid cancer pathogenesis through dual modulation of cellular proliferation, apoptosis, invasiveness, and angiogenesis.